Back to feed
CADLCandel Therapeutics, Inc.
CIK 0001841387 · last filing 4d ago · 2 insider transactions
Buy volume
$0
2 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
2 priced transactions
Disclosure radarcross-source convergence
Institution-led1/5 sources
26/100
Recent disclosures · timeline
- Form 44d ago
Director · filed
- Form 44d ago
Director · filed
Price · CADL
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
CADL insider flow· last 30 days
Buys Sellsnet +$0
No priced transactions in this range.
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data6 funds hold$79.26M reported valueNet accumulating(5 adding · 1 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| FMR LLC (Fidelity) | 10,987,017 | $53.84M | 0.0% | Add+33% |
| BlackRock Inc | 3,109,042 | $15.23M | 0.0% | Add+9% |
| Millennium Management LLC | 1,060,086 | $5.19M | 0.1% | New |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
4d ago Jun 23, 2026 | Manning Paul B Director | Buy · A | 32,000 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 23, 2026 | PAPA JOSEPH C Director | Buy · A | 32,000 | $0.00 | $0 | Neutral+2 | Deriv |